Report cover image

Global Japanese Encephalitis Vaccines Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 93 Pages
SKU # APRC20549444

Description

Summary

According to APO Research, The global Japanese Encephalitis Vaccines market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Japanese Encephalitis Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Japanese Encephalitis Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Japanese Encephalitis Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Japanese Encephalitis Vaccines include Bharat Biotech, Sanofi Pasteur, Valneva Products, GlaxoSmithKline and China National Biotec Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Japanese Encephalitis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Japanese Encephalitis Vaccines.
The Japanese Encephalitis Vaccines market size, estimations, and forecasts are provided in terms of sales volume (k doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Japanese Encephalitis Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Japanese Encephalitis Vaccines Segment by Company

Bharat Biotech
Sanofi Pasteur
Valneva Products
GlaxoSmithKline
China National Biotec Group
Japanese Encephalitis Vaccines Segment by Type

Attenuated Vaccines
Inactivated Vaccines
Japanese Encephalitis Vaccines Segment by Application

Adults
Children
Japanese Encephalitis Vaccines Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Japanese Encephalitis Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Japanese Encephalitis Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Japanese Encephalitis Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Japanese Encephalitis Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Japanese Encephalitis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

93 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Japanese Encephalitis Vaccines Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Japanese Encephalitis Vaccines Sales Estimates and Forecasts (2020-2031)
1.3 Japanese Encephalitis Vaccines Market by Type
1.3.1 Attenuated Vaccines
1.3.2 Inactivated Vaccines
1.4 Global Japanese Encephalitis Vaccines Market Size by Type
1.4.1 Global Japanese Encephalitis Vaccines Market Size Overview by Type (2020-2031)
1.4.2 Global Japanese Encephalitis Vaccines Historic Market Size Review by Type (2020-2025)
1.4.3 Global Japanese Encephalitis Vaccines Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Japanese Encephalitis Vaccines Sales Breakdown by Type (2020-2025)
1.5.2 Europe Japanese Encephalitis Vaccines Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Japanese Encephalitis Vaccines Sales Breakdown by Type (2020-2025)
1.5.4 South America Japanese Encephalitis Vaccines Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Japanese Encephalitis Vaccines Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Japanese Encephalitis Vaccines Industry Trends
2.2 Japanese Encephalitis Vaccines Industry Drivers
2.3 Japanese Encephalitis Vaccines Industry Opportunities and Challenges
2.4 Japanese Encephalitis Vaccines Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Japanese Encephalitis Vaccines Revenue (2020-2025)
3.2 Global Top Players by Japanese Encephalitis Vaccines Sales (2020-2025)
3.3 Global Top Players by Japanese Encephalitis Vaccines Price (2020-2025)
3.4 Global Japanese Encephalitis Vaccines Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Japanese Encephalitis Vaccines Major Company Production Sites & Headquarters
3.6 Global Japanese Encephalitis Vaccines Company, Product Type & Application
3.7 Global Japanese Encephalitis Vaccines Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Japanese Encephalitis Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Japanese Encephalitis Vaccines Players Market Share by Revenue in 2024
3.8.3 2023 Japanese Encephalitis Vaccines Tier 1, Tier 2, and Tier 3
4 Japanese Encephalitis Vaccines Regional Status and Outlook
4.1 Global Japanese Encephalitis Vaccines Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Japanese Encephalitis Vaccines Historic Market Size by Region
4.2.1 Global Japanese Encephalitis Vaccines Sales in Volume by Region (2020-2025)
4.2.2 Global Japanese Encephalitis Vaccines Sales in Value by Region (2020-2025)
4.2.3 Global Japanese Encephalitis Vaccines Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Japanese Encephalitis Vaccines Forecasted Market Size by Region
4.3.1 Global Japanese Encephalitis Vaccines Sales in Volume by Region (2026-2031)
4.3.2 Global Japanese Encephalitis Vaccines Sales in Value by Region (2026-2031)
4.3.3 Global Japanese Encephalitis Vaccines Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Japanese Encephalitis Vaccines by Application
5.1 Japanese Encephalitis Vaccines Market by Application
5.1.1 Adults
5.1.2 Children
5.2 Global Japanese Encephalitis Vaccines Market Size by Application
5.2.1 Global Japanese Encephalitis Vaccines Market Size Overview by Application (2020-2031)
5.2.2 Global Japanese Encephalitis Vaccines Historic Market Size Review by Application (2020-2025)
5.2.3 Global Japanese Encephalitis Vaccines Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Japanese Encephalitis Vaccines Sales Breakdown by Application (2020-2025)
5.3.2 Europe Japanese Encephalitis Vaccines Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Japanese Encephalitis Vaccines Sales Breakdown by Application (2020-2025)
5.3.4 South America Japanese Encephalitis Vaccines Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Japanese Encephalitis Vaccines Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Bharat Biotech
6.1.1 Bharat Biotech Comapny Information
6.1.2 Bharat Biotech Business Overview
6.1.3 Bharat Biotech Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bharat Biotech Japanese Encephalitis Vaccines Product Portfolio
6.1.5 Bharat Biotech Recent Developments
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Comapny Information
6.2.2 Sanofi Pasteur Business Overview
6.2.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments
6.3 Valneva Products
6.3.1 Valneva Products Comapny Information
6.3.2 Valneva Products Business Overview
6.3.3 Valneva Products Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Valneva Products Japanese Encephalitis Vaccines Product Portfolio
6.3.5 Valneva Products Recent Developments
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Comapny Information
6.4.2 GlaxoSmithKline Business Overview
6.4.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments
6.5 China National Biotec Group
6.5.1 China National Biotec Group Comapny Information
6.5.2 China National Biotec Group Business Overview
6.5.3 China National Biotec Group Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 China National Biotec Group Japanese Encephalitis Vaccines Product Portfolio
6.5.5 China National Biotec Group Recent Developments
7 North America by Country
7.1 North America Japanese Encephalitis Vaccines Sales by Country
7.1.1 North America Japanese Encephalitis Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Japanese Encephalitis Vaccines Sales by Country (2020-2025)
7.1.3 North America Japanese Encephalitis Vaccines Sales Forecast by Country (2026-2031)
7.2 North America Japanese Encephalitis Vaccines Market Size by Country
7.2.1 North America Japanese Encephalitis Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Japanese Encephalitis Vaccines Market Size by Country (2020-2025)
7.2.3 North America Japanese Encephalitis Vaccines Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Japanese Encephalitis Vaccines Sales by Country
8.1.1 Europe Japanese Encephalitis Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Japanese Encephalitis Vaccines Sales by Country (2020-2025)
8.1.3 Europe Japanese Encephalitis Vaccines Sales Forecast by Country (2026-2031)
8.2 Europe Japanese Encephalitis Vaccines Market Size by Country
8.2.1 Europe Japanese Encephalitis Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Japanese Encephalitis Vaccines Market Size by Country (2020-2025)
8.2.3 Europe Japanese Encephalitis Vaccines Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Japanese Encephalitis Vaccines Sales by Country
9.1.1 Asia-Pacific Japanese Encephalitis Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Japanese Encephalitis Vaccines Sales by Country (2020-2025)
9.1.3 Asia-Pacific Japanese Encephalitis Vaccines Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Japanese Encephalitis Vaccines Market Size by Country
9.2.1 Asia-Pacific Japanese Encephalitis Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Japanese Encephalitis Vaccines Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Japanese Encephalitis Vaccines Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Japanese Encephalitis Vaccines Sales by Country
10.1.1 South America Japanese Encephalitis Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Japanese Encephalitis Vaccines Sales by Country (2020-2025)
10.1.3 South America Japanese Encephalitis Vaccines Sales Forecast by Country (2026-2031)
10.2 South America Japanese Encephalitis Vaccines Market Size by Country
10.2.1 South America Japanese Encephalitis Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Japanese Encephalitis Vaccines Market Size by Country (2020-2025)
10.2.3 South America Japanese Encephalitis Vaccines Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Japanese Encephalitis Vaccines Sales by Country
11.1.1 Middle East and Africa Japanese Encephalitis Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2020-2025)
11.1.3 Middle East and Africa Japanese Encephalitis Vaccines Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Japanese Encephalitis Vaccines Market Size by Country
11.2.1 Middle East and Africa Japanese Encephalitis Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Japanese Encephalitis Vaccines Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Japanese Encephalitis Vaccines Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Japanese Encephalitis Vaccines Value Chain Analysis
12.1.1 Japanese Encephalitis Vaccines Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Japanese Encephalitis Vaccines Production Mode & Process
12.2 Japanese Encephalitis Vaccines Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Japanese Encephalitis Vaccines Distributors
12.2.3 Japanese Encephalitis Vaccines Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.